Jeffrey Kinell

Operting partner

DFW Capital Partners

Joined: 2014

Office Phone:

(201) 836-6000


  Pro - Try 1 Week Free
 

    and access,

  •     79K PE/M&A Contacts
  •     +
  •     4.6K PE Firms
  •     3.6K M&A Advisors
  •     198K Transactions
  •     201K Companies

  •     Market Services
  •     Build Lists
  •     Research Sectors
  •     Uncover Opportunities

Bio

Mr. Kinell is an experienced health care services executive. He has worked with DFW since January 2014, when he served as interim CEO and a board member of Evolution Research Group, a DFW IV portfolio company focused on clinical trials for special populations. Today, he serves on the Boards of Children’s Dental Health Associates, a DFW V portfolio company focused on pediatric dentistry, and Lotus Clinical Research, LLC, a DFW V portfolio company that specializes in science based clinical research for special populations. Mr. Kinell is the former CEO of Bracket Global, which offers an integrated suite of e-clinical solutions. Prior to this, he was the CEO of CRI Lifetree, a leading clinical research company focused on special populations. He also served as the co-CEO of MedOptions, a provider of behavioral health services to nursing homes and assisted living centers. Prior to that, he was the COO of Comprehensive Neuroscience, which conducted clinical trials in neuroscience. He has also served as the CFO of Kelson Pediatric, a manager and operator of pediatric clinics, CEO of a dialysis center operator and the CFO of a publicly traded provider of post-acute care services. Mr. Kinell is a graduate of the University of Vermont.

Education